Hologic – a global leader in women’s health – announced it completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on the development of minimally invasive solutions for women’s health, for about $350 million.
The Sonata System is a technology intended for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, such as those associated with heavy menstrual bleeding. And the technology combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incision-less procedure.
KEY QUOTES:
“We are excited to complete the acquisition of Gynesonics and to increase access to their Sonata® System, which complements and expands our range of minimally invasive solutions for heavy periods and fibroids. As global champions for women’s health, we are dedicated to empowering surgeons with diverse, cutting-edge treatment options as we strive to transform women’s lives for the better.”
– Brandon Schnittker, President of Surgical Solutions at Hologic
“As we embark on this new phase with Hologic, we are excited to see the continued success of the Sonata System, which has already made a difference in the lives of thousands of women. Hologic’s commitment to women’s health and their leadership in innovation make them a perfect fit for our organization.”
– Skip Baldino, President and Chief Executive Officer of Gynesonics
